Management of Massive Hemoptysis in Pulmonary Tuberculosis

Risk Stratification

Diagnostic Evaluation

Therapeutic Interventions

Bronchial Artery Embolization (BAE) Outcomes

Medical Management

Admission and Monitoring

Management of Hemoptysis in Patients with Pulmonary Tuberculosis

Initial Assessment and Management

• The American College of Radiology recommends proceeding directly to bronchial artery embolization (BAE) without delay in clinically unstable patients with massive hemoptysis, as delaying BAE significantly increases mortality 4, 5, 6
• Intubation with a single-lumen cuffed endotracheal tube is recommended to allow bronchoscopic suctioning and clot removal in unstable patients 5, 6
• BAE has immediate success rates of 73-99% in controlling bleeding, with tuberculosis being one of the most common etiologies in Asian studies showing 87-94% immediate success rates 7, 8, 4

Diagnostic Evaluation

• CT chest with IV contrast is the preferred diagnostic test to identify the cause and location of bleeding, with diagnostic accuracy of 80-90% and superior to bronchoscopy (77% vs 8% diagnostic yield) 4, 5
• The American College of Radiology recommends CT angiography as the standard of care for arterial planning if BAE is being considered 5

Specific Considerations for Post-TB Hemoptysis

• Tuberculosis sequelae are among the most common causes of hemoptysis, particularly in patients with cavitary disease, bronchiectasis, or aspergillomas developing in old TB cavities 7, 8
• Aspergillomas have the highest recurrence rate of hemoptysis (55%) after BAE, making definitive surgical treatment necessary following initial BAE for acute massive hemoptysis 5

Medical Management

• The American College of Chest Physicians recommends administering antibiotics for at least mild hemoptysis, as bleeding may represent a pulmonary exacerbation or superimposed bacterial infection 4
• NSAIDs and anticoagulants should be stopped immediately in patients with active hemoptysis, as they impair platelet function and worsen bleeding 4, 6

Post-Intervention Management and Follow-Up

• All patients should be admitted to intensive care for monitoring of coagulation parameters, hemoglobin, blood gases, and ongoing bleeding 5
• Recurrence of bleeding occurs in 10-55% of cases after BAE, with higher rates in TB patients, aspergillomas, malignancy, and sarcoidosis 4, 5